These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy. Mareschal J; Weber K; Rigoli P; Biason E; Frambati L; Gotteland C; Zilli T; Pichard C; Miralbell R Acta Oncol; 2017 Apr; 56(4):569-574. PubMed ID: 28075176 [TBL] [Abstract][Full Text] [Related]
7. Complications of androgen deprivation therapy in prostate cancer. Schwandt A; Garcia JA Curr Opin Urol; 2009 May; 19(3):322-6. PubMed ID: 19318949 [TBL] [Abstract][Full Text] [Related]
8. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues. Gomella LG BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166 [TBL] [Abstract][Full Text] [Related]
9. Sex or survival: short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy. Wilke DR; Krahn M; Tomlinson G; Bezjak A; Rutledge R; Warde P Cancer; 2010 Apr; 116(8):1909-17. PubMed ID: 20162716 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer. Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948 [TBL] [Abstract][Full Text] [Related]
11. Managing complications of androgen deprivation therapy for prostate cancer. Holzbeierlein JM Urol Clin North Am; 2006 May; 33(2):181-90, vi. PubMed ID: 16631456 [TBL] [Abstract][Full Text] [Related]